N-(4-Hydroxyphenyl)retinamide induces apoptosis in T lymphoma and T Lymphoblastoid leukemia cells

Leukemia and Lymphoma

Volumn 25, Issue 42067, 1997, Pages 271-280

  Chan, Lee Nien L ^a   Zhang, Shuliu ^a   Shag, Jinyi ^a   Waikela, Rebekah ^b   Thompson, E Aubrey ^a   Chan, Teh Sheng ^c  

^a University of Texas Medical Branch School of Medicine   (United States)

^b INDIANA UNIVERSITY   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

4 HPR; apoptosis; drug effect; lymphoid malignancies; retinoids

Indexed keywords

ANTILEUKEMIC AGENT; ANTINEOPLASTIC AGENT; DNA FRAGMENT; FENRETINIDE; GLUCOCORTICOID; RETINOIC ACID DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL KILLING; CELL VIABILITY; CONTROLLED STUDY; DRUG METABOLISM; DRUG POTENCY; DRUG RESISTANCE; DRUG SENSITIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHOID CELL; LYMPHOMA; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; T CELL LYMPHOMA; THYMOCYTE;

AMINOPHENOLS; ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; DNA FRAGMENTATION; DRUG RESISTANCE, NEOPLASM; FENRETINIDE; GLUCOCORTICOIDS; HUMANS; LEUKEMIA, T-CELL; LYMPHOCYTES; LYMPHOMA, T-CELL; MICE; MICE, INBRED BALB C; RETINOIDS; SPLEEN; STEREOISOMERISM; THYMUS GLAND; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0030976351     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428199709114166     Document Type: Article

References (25)

1. Formelli F., Clerici M., Campa T., DiMauro M. G., Magni A., Mascotti G., Moglia D., DePalomo G., Costa A., Veronesi U. Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations. J. Clin. Oncol. 1993; 11: 2036 – 2042
2. Costa A., Formelli F., Chiesa F., Decensi A., DePalo G., Veronesi U. Prospect of chemoprevention of human cancers with the synthetic retinoid fenretinide. Cancer Res. 1994; 54: 2032s – 2037s
3. Moon R. C., Thompson H. C., Becci P. J., Grubbs C. J., Gander R. J., Newton D. L., Smith J. M., Phillips S. L., Henderson W. R., Mullen L. T., Brown C. C., Sporn M. B. N-(4-hydroxphyenyl)retinamide, a new retinoid for prevention of breast cancer in the rat. Cancer Res. 1979; 39: 1339 – 1346
4. Mariotti A., Marcora E., Bunone G., Costa A., Veronesi U., Pierotti M. A., Valle G. D. N-(4-hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells. J. Natl. Cancer Inst. 1994; 86: 1245 – 1247
5. DeVinci A., Geido E., Infusini E., Giaretti W. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(hydroxyphenyl)retinamide (HPR) is a synthetic retinoid with anti-cancer properties and lower toxicity than all-trans retinoic acid (RA). Int. J. Cancer 1994; 3: 422 – 426
6. Delia D., Aiello A., Lombardi L., Pelicci P. G., Grignani F., Jr., Grignani F., Formelli F., Menard S., Costa A., Veronesi U., Pierotti M. A. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid. Cancer Res. 1993; 53: 6036 – 6041
7. Delia D., Aiello A., Formelli F., Fontanella E., Costa A., Miyashita T., Reed J. C., Pierotti M. A. Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulation bcl-2. Blood 1995; 85: 359 – 367
8. Sheikh M. S., Shao Z.-M., Li X.-S., Ordonez J. V., Conely B. A., Wu S., Quick T., Niles R. M., Fontana J. A. N-(4-hydroxyphenyl)retinamide (4-HPR)-mediated biological actions involve retinoid receptor-independent path-ways in human breast carcinoma. Carcinogenesis 1995; 16: 2477 – 2486
9. Norman M. R., Thompson E. B. Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res. 1977; 37: 3785 – 3791
10. Harmon J. M., Thompson E. B. Isolation and characterization of dexamethasone-resistant mutants from human lymphoid cell line CEM-C7. Mol. Cell. Biol. 1981; 1: 512 – 521
11. Zawydiwski R., Harmon J. M., Thompson E. B. Glucocorticoid-resistant human acute lymphoblastic leukemia cell line with functional receptor. Cancer Res. 1983; 43: 3865 – 3873
12. Thompson E. A., Jr. Properties of a cell-culture line derived from lymphosarcoma P1798. Mol. Cell. Endocrinol. 1979; 17: 95 – 102
13. Lucas K. L., Barbour K. W., Housley P. R., Thompson E. A., Jr. Biochemical and molecular characterization of glucocorticoid receptor of lymphosarcoma P1798 variants. Mol. Endocrinol. 1988; 2: 291 – 299
14. Thompson E. A., Jr. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response. Cancer Res. 1991; 51: 5551 – 5556
15. Mishell B., Shiigi S., Henry C., Chan E. Preparation of mouse cell suspensions. Selected Methods in Cellular Immunology, B. B. Mishell, S. M. Shiigi. Freeman, San Francisco 1980; 3 – 9; 24 – 25
16. Duke R. C., Cohen J. J. Morphological and biochemical assays of apoptosis. Current Protocols in Immunology. Wyllie, New York 1992; 3.17.7 – 3.17.8
17. Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 1989; 119: 203 – 210
18. Swanson B. N., Newton D. L., Roller P. P., Sporn M. B. Biotransformation and biological activity of N-(4-hydroxyphenyl)retinamide derivatives in rodents. J. Pharmacol. Exp. Ther. 1981; 219: 632 – 637
19. Thompson E. A. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel “slow death” phenotype. Cancer Res. 1991; 51: 5544 – 5550
20. Dillchay D. L., Li W., Kalin J., Walia A. S., Lamon E. W. In vitro effects of retinoids on murine thymus-dependent and thymus-independent mitogenesis. Cell. Immunol. 1987; 107: 130 – 137
21. Bunk M. J., Kinahan J. J., Sankar N. H. Biotransformation and protein binding of N-(4-hydroxyphenyl)retinamide in murine mammary epithelial cells. Cancer Lett. 1985; 26: 319 – 326
22. Dillehay D. L., Shealy Y. F., Lamon E. W. Inhibition of moloney murine lymphoma and sarcoma growth in vivo by dietary retinoids. Cancer Res. 1989; 49: 44 – 50
23. Evans R. M. The steroid and thyroid hormone receptor super-family. Science 1988; 240: 889 – 895
24. Chambon P. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog. Hormone Res. 1995; 50: 317 – 332
25. Kazmi S. M., Plante R. K., Voisconti V., Lau C. Y. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoic receptor-mediated gene expression in human breast cancer cell lines. Cancer Res. 1996; 56: 1056 – 1062